Skip to content

Mitochondrial DNA Analysis by Line Blot (CSF)

Published: August 9, 2026Updated: August 16, 2026

This test detects mitochondrial DNA in cerebrospinal fluid (CSF) to evaluate mitochondrial function or potential genetic mutations linked to neurological conditions.

Quick summary

["Assesses mitochondrial integrity in the brain’s fluid for rare genetic or neurological disorders."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
89539-1
Short code
Mitochondria M2 Ab CSF Ql Line blot
Synonyms
Mitochondria M2 Ab CSF Ql Line blot
Category
chemistry
Sample
csf
Container
Sterile tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
Specimen volume
1-2 mL
Stability
Immediate analysis required, Refrigerated: 1h
Hemolysis max
200
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like muscle weakness, seizures, vision problems, or neurological issues that could be linked to mitochondrial dysfunction. It’s also used in research or genetic counseling for suspected mitochondrial disorders.

What to Expect Before the Test

No special preparation is needed. A small sample of cerebrospinal fluid is collected via lumbar puncture (spinal tap) under sterile conditions. You may experience mild discomfort, but it’s usually temporary.

What the Test Measures

The line blot technique detects mitochondrial DNA fragments in CSF. Abnormal patterns may indicate mitochondrial DNA abnormalities, though results are interpreted in context with clinical findings and genetic testing.

How Results Are Used

Results help diagnose or monitor mitochondrial disorders, such as MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes), or guide genetic counseling for families at risk.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Mitochondrial DNA in CSF can reveal genetic mutations affecting energy production in brain cells. While rare, these mutations may cause progressive neurological diseases. The test is particularly useful for confirming suspected mitochondrial disorders in patients with unexplained symptoms, especially those with a family history of similar conditions.

Short name

Mitochondrial DNA Testing (Cerebrospinal Fluid)

Frequently asked questions

What does a positive or abnormal result mean?
An abnormal mitochondrial DNA pattern in CSF may suggest mitochondrial dysfunction or genetic mutations linked to neurological disorders. However, results alone don’t diagnose a condition—they’re part of a broader evaluation that includes clinical symptoms, family history, and sometimes additional genetic testing.
Can this test be used for screening healthy individuals?
No, this test is not typically used for routine screening in healthy individuals. It’s reserved for patients with suspected mitochondrial disorders or specific neurological symptoms that may warrant further genetic investigation.
How long does it take to get results?
Results are usually available within 1–2 weeks, depending on lab processing and confirmation steps. Your healthcare provider will discuss the timeline with you before the test.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy